Delivery Order SPE2DB20D3101-SPE2DB25FRBP7

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $30,906.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,566,915,639 Duloxetine HCL DR 60 MG capsules in 90-count packages. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,352.29 firm fixed-price delivery order is for the supply of 4,566,518,226 units of Duloxetine HCL DR 60 MG capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,355.93 firm fixed-price delivery order is for 4,562,647,491 units of Duloxetine HCL DR 60 mg capsules. The contract has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,958.73 with a period of performance through January 17, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the supply of 4,566,964 units of the drug Duloxetine HCl 60 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,562,967,827 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,070.83. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is December 4, 2023. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp is...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,028,341 units of Duloxetine HCL DR 60 MG capsules. The $1,492.81 firm fixed-price delivery order has a completion date of January 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen is the prime contractor and is a major pharmaceutical distributor that has extensive experience supporting federal healthcare programs, particularly within the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,564,603,974 units of Duloxetine HCL DR 60 MG capsules in 90-count packages, with a ceiling value of $9,128.77. The contract has an ultimate completion date of May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is a delivery order valued at $7,510.53 issued to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the supply of 4,562,766,402 units of Duloxetine HCl DR 60 mg capsules. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999 and running through November...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,215.82 firm fixed-price contract is for the delivery of 4,566,516,150 units of Duloxetine HCL DR 40 MG capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,342.68 firm fixed-price delivery order is for the supply of 4,566,692,596 units of Duloxetine HCL DR 40 mg capsules. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRBP7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $5,123.29, is for the delivery of 4,567,239,697 units of Duloxetine HCL DR 60 MG capsules.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/13/25, 9:42 AM